Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urti...
Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health‐related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, which can lead to depression, anxiety, social, and work‐related problems.
Methods
This randomized, doub...
Alternative Titles
Full title
Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c654749ec2044c6fa71aef8c27a9caa8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c654749ec2044c6fa71aef8c27a9caa8
Other Identifiers
ISSN
2045-7022
E-ISSN
2045-7022
DOI
10.1002/clt2.12121
